• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » March 2002 – The CenterWatch Monthly : Volume 9, Issue 3, March 2002
March 2002 – The CenterWatch Monthly : Volume 9, Issue 3, March 2002

March 2002 – The CenterWatch Monthly : Volume 9, Issue 3, March 2002

$79.00

Product Details

Top AHCs Turn Away from Industry-Sponsored Trials

Centralized clinical trial offices at select academic health centers are consolidating in the wake of a renewed commitment to conduct basic and translational research. This consolidation may drive growth for independent investigative sites and AHCs pursuing industry-sponsored clinical trials.

Sponsors Take on Patient Recruitment

The majority of top pharmaceutical companies have now established centralized patient-recruitment functions. These functions provide a variety of support services designed to address inefficiencies throughout the clinical trial process.

CentreStage Europe: A Guide to Conferences in Europe

It ’s conference season once again in Europe.Seve al conference organizers have noted an increased interest from Americans who wish to present at the European conferences,seeing additional opportunities to gain exposure for their companies and products.

Eye On: Colorectal Cancer

Colon cancer is the second most common cause of cancer death today. One hundred and fifty thousand new cases of colon cancer are diagnosed every year.In addition to ever-improving screening and detection modalities, there are many areas of colorectal cancer drug development underway. CenterWatch Drug Intelligence has identified a total of 42 drugs in the pipeline.

  • Month in Review
  • In the Pipeline
  • Opportunities Underway
  • TrialWatch
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing